Live Feeds
Press Releases
Insider Trading
FDA Approvals
Analyst Ratings
Insider Trading
SEC filings
Market insights
Analyst Ratings
Alerts
Subscriptions
Settings
RSS Feeds
Live Feeds
Press Releases
Insider Trading
FDA Approvals
Analyst Ratings
Insider Trading
SEC filings
Market insights
Analyst Ratings
Alerts
Subscriptions
Settings
RSS Feeds
Publish
Dashboard
Subscribe to $ATYR
aTyr Pharma Inc.
Subscribe to $ATYR
$ATYR
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
IPO Year: 2015
Exchange: NASDAQ
Recent Analyst Ratings for aTyr Pharma Inc.
Date
Price Target
Rating
Analyst
2/18/2025
$16.00
Outperform
Leerink Partners
1/6/2025
Overweight
Cantor Fitzgerald
10/4/2024
$17.00
Overweight
Wells Fargo
9/5/2024
$9.00
Buy
Jefferies
See more ratings
